Human Organic Solute Transporter αβ (OSTα–OSTβ) Modeling Services
CD ComputaBio provides cutting-edge software-based virtual services to empower researchers, but we do not offer free software packages.
As the pharmaceutical landscape shifts toward a more nuanced understanding of enterohepatic circulation and metabolic homeostasis, the Human Organic Solute Transporter alpha-beta (OSTα–OSTβ) has emerged as a pivotal target. Unlike the classical SLC family transporters that often function as monomers or homodimers, the OSTα–OSTβ complex represents a unique heteromeric solute carrier system (SLC51A/B) essential for the efflux of bile acids and steroid conjugates.
CD ComputaBio provides an integrated suite of Structure, Mechanism & Drug Interaction Analysis Services to accelerate your drug discovery programs targeting this unconventional transporter.
Human Organic Solute Transporter αβ (OSTα–OSTβ) Introduction
Bile acids (BAs) serve as essential amphipathic surfactants, playing diverse roles as regulators in various physiological processes such as nutrient absorption and distribution, lipid metabolism, and inflammation. The human organic solute transporter αβ (OSTα–OSTβ, hereafter referred to as OSTα/β) transports BAs, playing a pivotal role in their secretion and distribution. Pathogenic mutations in OSTα/β have been linked to cholestasis. Despite the significance of OSTα/β in maintaining BA homeostasis, the specific stoichiometry and assembly of the complex, as well as the molecular mechanisms governing BA transport by OSTα/β, remain largely uncharacterized.
Figure 1. Cryo-EM map of OSTα/β. OSTα is in pink and green, OSTβ in blue, glycans in cyan, cholesterols in orange, lipids in grey and palmitoylation in red.1
Physiological Roles of OSTα–OSTβ
OSTα–OSTβ is the "exit valve" of the enterocyte. After bile acids (BAs) are taken up from the intestinal lumen by ASBT, OSTα–OSTβ mediates their secretion into the portal blood. Its expression in the intestine, liver, brain, and adrenal glands underscores its role in managing systemic BA levels and steroid hormone signaling.
Structural Features of OSTα–OSTβ
Recent advances in Cryo-EM have redefined our understanding of this transporter's architecture.
Novel Fold and Stoichiometry
The complex is organized as a dimer of heterodimers (a tetrameric assembly).
OSTα: Exhibits a unique 7-transmembrane (7-TM) fold reminiscent of GPCRs but structurally distinct, defining a new class of transporters.
OSTβ: A single-pass accessory subunit that "wraps" around the OSTα core, stabilizing the assembly and enabling membrane trafficking.
Lipidic Stabilization and Palmitoylation
The structural integrity of OSTα–the lipid environment heavily influences OSTβ. Palmitoylation at a cysteine-rich motif in the cytosolic domain of OSTα anchors the protein to the membrane, creating a lateral substrate-binding groove—a feature that distinguishes it from classical "pore-based" transporters.
Transport Mechanisms Analysis of OSTα–OSTβ
Based on the latest structural evidence, OSTα–OSTβ operates through a novel mechanism distinct from the classical "alternating-access" model. Two primary models have been proposed to describe how this proteolipid conduit functions:
Transport Mechanisms One
Yang et al.2 introduced the "Tunnel Model," proposing that within a protein, a "tunnel" is formed by hydrophilic amino acids. In this model, bile acids enter through the membrane and smoothly travel down the tunnel to exit the cell, akin to sliding down a slide. This one-way passage is regulated by a "gate."
Transport Mechanisms Two
In contrast, Wang et al.1 proposed the "Scramblase-like Model," suggesting that Ostα/β operates more like a "lipid scramblase." According to this model, the protein features a positively charged cavity at its center, which attracts negatively charged bile acids. This mechanism facilitates an "inverted flip" motion, allowing bile acids to cross the membrane from one side to the other.
CD ComputaBio's OSTα–OSTβ Integrated Solutions
CD ComputaBio offers bespoke computational workflows to bridge the gap between static structures and dynamic transport functions.
CD ComputaBio utilizes μs-scale MD simulations to bridge the gap between static structures and dynamic functions in a complex lipid environment.
A. Applications of OSTα–OSTβ MD
By leveraging high-resolution, microsecond-scale molecular dynamics (MD) simulations, we offer specialized insights into the OSTα–OSTβ heterocomplex. Our services empower clients in the following strategic areas:
Elucidating Lateral Transport Mechanisms
We simulate the precise trajectory of substrates (e.g., bile acids, DHEAS) as they transition from the lipid bilayer into the transport channel via the lateral openings of OSTα. These simulations provide robust computational validation for the "lateral access protected lipid conduit" model, offering a granular view of substrate-membrane-protein interactions.
Quantifying Post-Translational Modification (PTM) Effects
Our simulations provide a quantitative assessment of how palmitoylation within the ICL2 region influences complex stability. We reveal the mechanical link between lipid modifications and the conformational dynamics of the 7-TM core, helping you understand how PTMs regulate protein longevity and function within the membrane.
Mapping Drug Efflux and Transport Kinetics
We track the movement of clinical compounds—such as rosuvastatin—through the transport pore to identify bottleneck regions and high-affinity binding sites. By pinpointing these "rate-limiting steps," we can accurately predict drug transport efficiency, potential drug-drug interactions, or inhibitory profiles.
Investigating Voltage-Sensitive Gating
To understand the transporter's response to the cellular environment, we observe substrate flux under specific transmembrane potentials. This includes a detailed analysis of how key residues, such as Lys191, respond to electric fields, providing a molecular blueprint of the complex's voltage-sensing capabilities.
B. Past Case of Our MD Services
Project Background: Abnormal aggregation of hIAPP is a key pathological feature of type 2 diabetes. The client sought to explore, using computational methods, the inhibitory mechanism of the natural product silibinin on amyloid fiber formation.
Research Content: We performed 200 ns all-atom MD simulations of hIAPP monomers and oligomers in complex with silibinin. Through trajectory analysis, we identified the core hydrophobic region of hIAPP that binds to silibinin (composed of residues such as Phe15 and Tyr37).
Project Results: The simulation results showed that silibinin inhibits the expansion of β-sheets through competitive binding. This case fully demonstrates the technical reliability of CD ComputaBio in handling precise protein-ligand interactions and long-range conformational evolution.
Figure 2. Binding Pockets Analysis. (Analysis of human amyloid polypeptide and silibinin after 200 ns of molecular dynamics simulation.)
C. Workflow of OSTα–OSTβ MD
System Preparation: Embedding the Cryo-EM structure into a customized POPC/Cholesterol bilayer with palmitoylation.
Equilibration: NVT/NPT ensembles to stabilize the membrane-protein complex.
Production Run: 1–5 μs of unrestrained simulation on high-performance clusters.
Trajectory Analysis: Calculating RMSD, hydrogen bond networks, and free energy landscapes of transport.
A. Substrate Mapping: High-throughput docking to identify binding affinities for bile acid derivatives.
B. DDI Risk Assessment: Screening for potential inhibitors that might cause cholestatic side effects.
C. Virtual Screening: Discovery of novel modulators for the treatment of NASH or cholestasis.
Electrochemical Potential Analysis
Since OSTα–OSTβ is voltage-sensitive, we apply Electric Field-Coupled MD to simulate physiological membrane potentials, providing a realistic view of how voltage influences substrate efflux.
Published Data
This research, published in Nature, reveals the high-resolution cryo-EM structure and functional mechanism of the human organic solute transporter OSTα-OSTβ, a critical mediator of BA homeostasis, unlike other bile acid transporters that rely on active transport, OSTα-OSTβ functions as a bidirectional uniporter that facilitates the movement of BAs and sterols down their electrochemical gradients. The transport mechanism centers on a hydrophilic, positively charged cavity—defined by the key residue K191-that attracts the negative moiety of bile acids. Molecular dynamics simulations further demonstrate that substrates undergo a distinct "head-down" to "head-up" conformational flip within this proteolipid pathway to complete translocation across the membrane, a process fundamentally different from the canonical alternating-access mechanism used by other transporters.
Figure 3. MetaD simulations of BA translocation and the transport model.1
Frequently Asked Questions
Connect with Us Anytime!
The recent high-resolution structural revelations of the human OSTα–OSTβ complex have fundamentally shifted our understanding of bile acid and steroid homeostasis. This non-canonical, 7-TM heteromeric transporter represents a significant milestone in membrane protein biology, offering a sophisticated "proteolipid conduit" for the facilitated diffusion of metabolic and pharmaceutical compounds. At CD ComputaBio, we transform these static structural snapshots into dynamic, actionable insights. By integrating microsecond-scale Molecular Dynamics (MD), specialized voltage-sensitive simulations, and mechanism-guided virtual screening, we provide a robust platform. Contact us today to schedule a technical consultation with our computational biology team and learn how our OSTα–OSTβ specialized services can accelerate your drug discovery pipeline.
Figure 1. Cryo-EM map of OSTα/β. OSTα is in pink and green, OSTβ in blue, glycans in cyan, cholesterols in orange, lipids in grey and palmitoylation in red.1
Figure 2. Binding Pockets Analysis. (Analysis of human amyloid polypeptide and silibinin after 200 ns of molecular dynamics simulation.)
Figure 3. MetaD simulations of BA translocation and the transport model.1